EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,472,084 | -29.9% | 445,139 | -26.1% | 0.00% | 0.0% |
| Q2 2023 | $4,955,974 | -3.2% | 602,184 | -14.7% | 0.00% | 0.0% |
| Q1 2023 | $5,118,907 | -36.0% | 706,056 | -21.7% | 0.00% | -50.0% |
| Q4 2022 | $8,002,062 | -41.4% | 902,149 | -19.1% | 0.00% | -33.3% |
| Q3 2022 | $13,657,000 | +46.6% | 1,115,723 | +41.6% | 0.00% | +50.0% |
| Q2 2022 | $9,319,000 | -22.9% | 787,720 | +23.9% | 0.00% | -33.3% |
| Q1 2022 | $12,088,000 | -53.8% | 635,549 | -35.5% | 0.00% | -40.0% |
| Q4 2021 | $26,155,000 | -54.3% | 985,154 | -29.3% | 0.01% | -58.3% |
| Q3 2021 | $57,251,000 | +24.7% | 1,393,629 | +71.9% | 0.01% | +20.0% |
| Q2 2021 | $45,907,000 | +20.4% | 810,513 | -10.7% | 0.01% | 0.0% |
| Q1 2021 | $38,135,000 | -47.1% | 907,979 | -11.7% | 0.01% | -44.4% |
| Q4 2020 | $72,123,000 | +159.7% | 1,028,692 | +4.0% | 0.02% | +125.0% |
| Q3 2020 | $27,767,000 | +21.4% | 989,558 | +28.0% | 0.01% | +14.3% |
| Q2 2020 | $22,868,000 | +74.9% | 773,085 | +17.2% | 0.01% | +40.0% |
| Q1 2020 | $13,076,000 | -38.9% | 659,408 | -8.8% | 0.01% | 0.0% |
| Q4 2019 | $21,398,000 | +39.3% | 722,661 | +7.0% | 0.01% | +25.0% |
| Q3 2019 | $15,359,000 | -22.3% | 675,418 | -15.5% | 0.00% | -33.3% |
| Q2 2019 | $19,773,000 | +21.7% | 799,258 | +20.3% | 0.01% | +20.0% |
| Q1 2019 | $16,248,000 | +8.5% | 664,531 | +0.9% | 0.01% | 0.0% |
| Q4 2018 | $14,981,000 | +1.9% | 658,498 | +42.5% | 0.01% | +25.0% |
| Q3 2018 | $14,704,000 | +22.2% | 462,076 | +37.6% | 0.00% | +33.3% |
| Q2 2018 | $12,032,000 | +5.9% | 335,812 | -2.1% | 0.00% | 0.0% |
| Q1 2018 | $11,367,000 | +31.0% | 342,924 | +21.5% | 0.00% | +50.0% |
| Q4 2017 | $8,674,000 | -13.6% | 282,286 | -32.5% | 0.00% | 0.0% |
| Q3 2017 | $10,037,000 | +73.3% | 418,086 | +21.1% | 0.00% | +100.0% |
| Q2 2017 | $5,793,000 | +651.4% | 345,266 | +899.1% | 0.00% | – |
| Q1 2017 | $771,000 | +60.3% | 34,559 | +16.7% | 0.00% | – |
| Q4 2016 | $481,000 | -17.9% | 29,614 | -32.0% | 0.00% | – |
| Q3 2016 | $586,000 | -52.6% | 43,531 | -14.0% | 0.00% | – |
| Q2 2016 | $1,236,000 | -48.6% | 50,641 | -27.3% | 0.00% | -100.0% |
| Q1 2016 | $2,405,000 | – | 69,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |